Clinical Trials Browser

INDUSTRY × Has results × Margins of Excision × Clear all

NCT04918381 2023-01-11

CellFX Treat & Resect Low-Risk BCC Feasibility Study

Phase NA Completed

30 enrolled 6 charts

Margins of Excision, Carcinoma, Basal Cell

NCT00719264 2017-03-20

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

Phase 2 Completed

365 enrolled 14 charts

Margins of Excision, Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell